 Laura Foster
Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 6 | 2025 | 99 | 1.110 |
Why?
| | Motor Neuron Disease | 1 | 2018 | 21 | 0.560 |
Why?
| | Brachial Plexus Neuritis | 1 | 2018 | 3 | 0.550 |
Why?
| | Hypesthesia | 1 | 2018 | 21 | 0.540 |
Why?
| | Muscle Weakness | 1 | 2018 | 92 | 0.510 |
Why?
| | Voltage-Gated Sodium Channel Blockers | 1 | 2016 | 7 | 0.500 |
Why?
| | Mexiletine | 1 | 2016 | 6 | 0.500 |
Why?
| | NAV1.2 Voltage-Gated Sodium Channel | 1 | 2016 | 8 | 0.500 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2016 | 20 | 0.490 |
Why?
| | Muscular Diseases | 1 | 2016 | 108 | 0.470 |
Why?
| | Anticonvulsants | 1 | 2016 | 242 | 0.410 |
Why?
| | Epilepsy | 1 | 2016 | 386 | 0.350 |
Why?
| | Trehalose | 1 | 2025 | 35 | 0.230 |
Why?
| | Diagnosis, Differential | 2 | 2018 | 1501 | 0.200 |
Why?
| | Enzyme Inhibitors | 1 | 2025 | 819 | 0.170 |
Why?
| | Ventilator Weaning | 1 | 2021 | 39 | 0.170 |
Why?
| | Neurologists | 2 | 2020 | 23 | 0.170 |
Why?
| | Burnout, Professional | 2 | 2018 | 483 | 0.160 |
Why?
| | Airway Extubation | 1 | 2021 | 60 | 0.160 |
Why?
| | Models, Organizational | 1 | 2020 | 143 | 0.150 |
Why?
| | Medicine | 1 | 2021 | 125 | 0.150 |
Why?
| | Neurology | 2 | 2018 | 114 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 150 | 0.150 |
Why?
| | Paintings | 1 | 2018 | 2 | 0.140 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2018 | 3 | 0.140 |
Why?
| | Job Satisfaction | 2 | 2018 | 235 | 0.140 |
Why?
| | Terminal Care | 1 | 2021 | 282 | 0.130 |
Why?
| | Arm | 1 | 2018 | 110 | 0.130 |
Why?
| | Family Health | 1 | 2018 | 191 | 0.130 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2016 | 141 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 603 | 0.110 |
Why?
| | Palliative Care | 2 | 2021 | 1008 | 0.110 |
Why?
| | Disease Management | 1 | 2018 | 647 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 415 | 0.100 |
Why?
| | Administration, Oral | 1 | 2016 | 847 | 0.100 |
Why?
| | Humans | 15 | 2025 | 144298 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2016 | 334 | 0.090 |
Why?
| | Ischemic Preconditioning | 1 | 2011 | 47 | 0.080 |
Why?
| | Male | 9 | 2025 | 72263 | 0.080 |
Why?
| | Double-Blind Method | 2 | 2025 | 2032 | 0.080 |
Why?
| | Middle Aged | 6 | 2025 | 35892 | 0.080 |
Why?
| | Internship and Residency | 1 | 2017 | 1261 | 0.060 |
Why?
| | Aged | 5 | 2025 | 25901 | 0.060 |
Why?
| | Adult | 5 | 2025 | 40408 | 0.060 |
Why?
| | Mutation | 1 | 2016 | 4068 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 79 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2016 | 6387 | 0.050 |
Why?
| | Blood Pressure | 1 | 2011 | 1763 | 0.050 |
Why?
| | Hypoxia | 1 | 2011 | 1193 | 0.050 |
Why?
| | Infant | 1 | 2016 | 10011 | 0.050 |
Why?
| | Cannula | 1 | 2021 | 27 | 0.040 |
Why?
| | Student Health Services | 1 | 2020 | 15 | 0.040 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2021 | 89 | 0.040 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2020 | 80 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 3180 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2021 | 282 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2025 | 11713 | 0.040 |
Why?
| | Exercise | 1 | 2011 | 2183 | 0.040 |
Why?
| | Female | 6 | 2025 | 78137 | 0.040 |
Why?
| | Patient Care Planning | 1 | 2020 | 168 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 266 | 0.030 |
Why?
| | Depersonalization | 1 | 2017 | 7 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2844 | 0.030 |
Why?
| | Work-Life Balance | 1 | 2017 | 22 | 0.030 |
Why?
| | DNA Helicases | 1 | 2018 | 141 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2018 | 338 | 0.030 |
Why?
| | Personal Satisfaction | 1 | 2018 | 220 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2018 | 262 | 0.030 |
Why?
| | Prognosis | 1 | 2023 | 4293 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1537 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1693 | 0.020 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2011 | 37 | 0.020 |
Why?
| | United States | 2 | 2020 | 15979 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2836 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3324 | 0.020 |
Why?
| | Leg | 1 | 2011 | 239 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 605 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8265 | 0.020 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1124 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2021 | 17104 | 0.010 |
Why?
| | Risk Factors | 1 | 2017 | 10783 | 0.010 |
Why?
|
|
Foster's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|